Evidence map›Paper›PMID 23451166›Full record

Trial reportPloS one2013

Importance of weight loss maintenance and risk prediction in the prevention of type 2 diabetes: analysis of European Diabetes Prevention Study RCT.

Linda Penn, Martin White, Jaana Lindström, Annemieke Th den Boer, Ellen Blaak, Johan G Eriksson, Edith Feskens, Pirjo Ilanne-Parikka, Sirkka M Keinänen-Kiukaanniemi, Mark Walker and 3 more

4 registry-linked trialsAbstract readRandomized Controlled Trial
In one paragraph

Trial report in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It reports registered trial NCT02503865. Cited by 68 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed, 8 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02503865 phase1 / phase2completed

Phase 1-2 Study of Development of Rational Ways of Medical and Non-medical Treatment Methods for Metabolic Syndrome

Ran2003Enrolled351Registered outcomes5Posted comparisons0ConditionsMetabolic SyndromeArms"Analimentary detoxication", Xenical, Pionorm, Diroton, Diltiazem, Atorvastatin
PMID 23176668PMID 22140269other papers from this trial
Open the trial in the graph
NCT00381186 nacompletednot on this map

Impact of 3-year Lifestyle Intervention on Postprandial Glucose Metabolism: the SLIM Study

TypeinterventionalSponsorMaastricht University Medical CenterRan1999 to 2006Enrolled150ConditionsImpaired Glucose Tolerance, Type 2 DiabetesArmsdiet- and exercise intervention
NCT00518167 naunknown statusnot on this map

The Finnish Diabetes Prevention Study: A Follow-up Study on the Effect of a Dietary and Exercise Intervention in the Prevention of Diabetes and Its Vascular Complications

TypeinterventionalSponsorFinnish Institute for Health and WelfareRan1993 to 2023Enrolled522ConditionsType 2 DiabetesArmsIntensive lifestyle counselling
NCT02450500 nacompletednot on this mapstarted 2015, after this paper: background citation

Prohealth@Home: A Feasibility Study Investigating the Application of a Web Based Lifestyle App to Improve Glycaemic Control by Changing Dietary and Activity Behaviours in Individuals at High Risk of Type 2 Diabetes

TypeinterventionalSponsorUniversity of PlymouthRan2015 to 2016Enrolled10ConditionsPre-diabetesArmsLifestyle counselling
3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 8 syntheses or guidelines pooled it.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Guideline
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Cost-effectiveness of implementing the National Health Service England Diabetes Prevention Programme in Canada: a modelling study.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2026
    Article
  16. Observational
  17. Article
  18. Review
  19. Article
  20. Review

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Linda PennInstitute of Health and Society, Newcastle University, Newcastle upon Tyne, United Kingdom. linda.penn@ncl.ac.uk
Martin White
Jaana Lindström
Annemieke Th den Boer
Ellen Blaak
Johan G Eriksson
Edith Feskens
Pirjo Ilanne-Parikka
Sirkka M Keinänen-Kiukaanniemi
Mark Walker
John C Mathers
Matti Uusitupa
Jaakko Tuomilehto

Funding

Medical Research Council MR/K02325X/1Wellcome TrustWellcome Trust 057146/Z/99/Z
6 · The paper itself

Abstract

backgroundPrevalence of type 2 diabetes (T2D) is increasing worldwide. T2D prevention by lifestyle intervention is effective. Pragmatic scalable interventions are needed, with evidence to efficiently target and monitor such interventions. We report pooled analyses of data from three European trial cohorts: to analyse T2D incidence, sustained weight loss and utility of risk predictors.

methodsWe analysed data on 749 adults with impaired glucose tolerance (278 men and 471 women, mean age 56 years, mean BMI 31 kgm(-2)) recruited between 1993 and 2003, and randomised to intensive lifestyle intervention (I) or lifestyle advice control (C). The intervention aimed to increase physical activity, modify diet, and promote weight loss≥5%. Using Cox-regression survival analysis, we assessed T2D incidence and the impact on T2D incidence of sustained weight loss, and of baseline cut-point values of FINDRISC score, fasting plasma glucose (FPG), and HbA1c.

resultsMean follow-up duration was 3.1 years. T2D was diagnosed in 139 participants (I = 45/379, C = 94/370). Cumulative T2D incidence was 57% lower in the intervention compared with the control group (HR 0.42 (95% CI 0.29 to 0.60) P<0.001). Participants with ≥5% weight loss at one year had 65% lower T2D incidence (HR 0.35 (95% CI 0.22 to 0.56) P<0.001); maintaining ≥5% weight loss for two and three years further reduced T2D incidence. Recommended cut-points to identify those at high risk for T2D would have identified different proportions of European Diabetes Prevention Study (EDIPS) participants with similar hazard-ratios for intervention effect.

conclusionsPooled analysis of EDIPS trial data reinforces evidence for T2D prevention by lifestyle intervention. Analysis showed the preventive effect of ≥5% weight loss, especially if maintained long term, which has utility for intervention monitoring. Analysis of proposed cut-points demonstrates difficulties in balancing risk and benefit, to efficiently target interventions and suggests evidence is needed to define clinical policy. TRIAL REGISTRATIONS: THE FINNISH DIABETES PREVENTION STUDY, HELSINKI, FINLAND: ClinicalTrials.gov; NCT00518167 The SLIM diabetes prevention study, Maastricht, The Netherlands: Clinical Trials.gov; NCT00381186 The EDIPS-Newcastle diabetes prevention study, Newcastle upon Tyne, UK: International Standard Randomised Controlled Trial Number; ISRCTN15670600.

Indexed as

Weight LossDiabetes Mellitus, Type 2EuropeFemaleHumansHyperglycemiaIncidenceLife StyleMaleMiddle Aged

Identifiers

PMID23451166
PMCPMC3581561

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.